Research graph
References from Beyond flow cytometry: Emerging cellular assays. Local targets link to admitted publications; unresolved targets remain external evidence.
Malignant pleural effusion and cancer of unknown primary site: A review of literature
10.21037/atm.2019.06.33 · 2019 · External reference
Recent advances for cancer detection and treatment by microfluidic technology, review and update
10.1186/s12575-022-00166-y · 2022 · External reference
Applications and analysis of targeted genomic sequencing in cancer studies
10.1016/j.csbj.2019.10.004 · 2019 · External reference
Navigating circulating tumour cells and tumour microemboli: Where we stand in bridging their molecular dynamics with clinical translation
10.1016/j.bbcan.2025.189384 · 2025 · External reference
Extracellular vesicles in lung cancer: Implementation in diagnosis and therapeutic perspectives
10.3390/cancers16111967 · 2024 · External reference
Multi-OMICS approaches in cancer biology: New era in cancer therapy
10.1016/j.bbadis.2024.167120 · 2024 · External reference
Somatic genomic testing in patients with metastatic or advanced cancer: ASCO provisional clinical opinion
10.1200/jco.21.02767 · 2022 · External reference
Clinical utility of pleural effusion supernatant cell-free DNA genotyping in previously treated patients with advanced non-small-cell lung cancer and disease progression: A multicenter retrospective study
10.1016/j.esmoop.2025.106023 · 2026 · External reference
Profiling Cell-Free DNA from malignant pleural effusion for oncogenic driver mutations in patients with treatment-naive stage IV adenocarcinoma: A multicenter prospective study
10.1007/s40291-024-00736-8 · 2024 · External reference
Analysis of pre-analytic factors affecting the success of clinical next-generation sequencing of solid organ malignancies
10.3390/cancers7030859 · 2015 · External reference
Sensitive cell-free tumor DNA analysis in supernatant pleural effusions supports therapy selection and disease monitoring of lung cancer patients
10.1016/j.ctarc.2021.100449 · 2021 · External reference
RNA sequencing and its applications in cancer and rare diseases
10.1007/s11033-021-06963-0 · 2022 · External reference
Good laboratory practice for clinical next-generation sequencing informatics pipelines
10.1038/nbt.3237 · 2015 · External reference
Comprehensive review on the clinical impact of next-generation sequencing tests for the management of advanced cancer
2023 · External reference
Comprehensive review on the clinical impact of next-generation sequencing tests for the management of advanced cancer
2025 · External reference
Molecular profiling of malignant pleural effusions with next generation sequencing (NGS): Evidence that supports its role in cancer management
10.3390/jpm10040206 · 2020 · External reference
Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling
10.1111/1759-7714.13006 · 2019 · External reference
Next generation sequencing (NGS) of malignant effusions and comparison to blood liquid biopsy (ctDNA): A community experience
10.1200/jco.2025.43.16_suppl.e20661 · 2025 · External reference
Emerging immunotherapeutic strategies for malignant serous effusions: Current evidence and future directions
2026 · External reference
RNA sequencing: New technologies and applications in cancer research
10.1186/s13045-020-01005-x · 2020 · External reference
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of clinical genome resource (ClinGen), cancer genomics consortium (CGC), and variant interpretation for cancer consortium (VICC)
10.1016/j.gim.2022.01.001 · 2022 · External reference
Guidelines for validation of next-generation sequencing–based oncology panels: A joint consensus recommendation of the association for molecular pathology and college of american pathologists
10.1016/j.jmoldx.2017.01.011 · 2017 · External reference
Next-generation sequencing in oncology: Genetic diagnosis, risk prediction and cancer classification
10.3390/ijms18020308 · 2017 · External reference
Application of next-generation sequencing to realize principles of precision therapy in management of cancer patients
10.15407/exp-oncology.2024.04.295 · 2024 · External reference
An NGS workflow blueprint for DNA sequencing data and its application in individualized molecular oncology
2016 · External reference
Exosomes in early lung cancer diagnostics: The current state of progress made and prospects
10.3389/fcell.2025.1739242 · 2026 · External reference
Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): An International Cancer Benchmarking Partnership (ICBP) population-based study
10.1016/s1470-2045(22)00127-9 · 2022 · External reference
Areas of crush nuclear streaming should be included as tumor content in the era of molecular diagnostics
10.3390/cancers15061910 · 2023 · External reference
ctDNA from body fluids is an adequate source for EGFR biomarker testing in advanced lung adenocarcinoma
10.1515/cclm-2020-1465 · 2021 · External reference
Current status and progress of PD-L1 detection: Guiding immunotherapy for non-small cell lung cancer
10.1007/s10238-024-01404-1 · 2024 · External reference
Implementation of a customized tertiary analysis platform for the reporting of somatic variants
10.1177/11772719231178618 · 2023 · External reference
Malignant pleural effusion
2025 · External reference
Clinical practice guidelines for pre-analytical procedures of plasma epidermal growth factor receptor variant testing
10.3343/alm.2022.42.2.141 · 2021 · External reference
Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing
10.1016/j.ctrv.2023.102649 · 2024 · External reference
From sample to sequencing: The importance of pre-analytical sample treatment in NGS analysis of patients with chronic lymphocytic leukemia
10.3390/cancers17223668 · 2025 · External reference
Lung cancer driver mutation testing using pleural effusion [Internet]. pleural diseases - anatomy, physiology, and pathophysiology
2025 · External reference
Single-cell RNA sequencing captures patient-level heterogeneity and associated molecular phenotypes in breast cancer pleural effusions
10.1002/ctm2.1356 · 2023 · External reference
Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers
10.1186/s12885-022-09922-5 · 2022 · External reference
Application of the metagenomic next-generation sequencing technology to identify the causes of pleural effusion
2025 · External reference
Spatial transcriptomics technology in cancer research
10.3389/fonc.2022.1019111 · 2022 · External reference
Single-cell RNA sequencing captures patient-level heterogeneity and associated molecular phenotypes in breast cancer pleural effusions
10.1002/ctm2.1356 · ExternalCitation · doi-reference
Current status and progress of PD-L1 detection: Guiding immunotherapy for non-small cell lung cancer
10.1007/s10238-024-01404-1 · ExternalCitation · doi-reference
RNA sequencing and its applications in cancer and rare diseases
10.1007/s11033-021-06963-0 · ExternalCitation · doi-reference
Profiling Cell-Free DNA from malignant pleural effusion for oncogenic driver mutations in patients with treatment-naive stage IV adenocarcinoma: A multicenter prospective study
10.1007/s40291-024-00736-8 · ExternalCitation · doi-reference
Multi-OMICS approaches in cancer biology: New era in cancer therapy
10.1016/j.bbadis.2024.167120 · ExternalCitation · doi-reference
Navigating circulating tumour cells and tumour microemboli: Where we stand in bridging their molecular dynamics with clinical translation
10.1016/j.bbcan.2025.189384 · ExternalCitation · doi-reference
Applications and analysis of targeted genomic sequencing in cancer studies
10.1016/j.csbj.2019.10.004 · ExternalCitation · doi-reference
Sensitive cell-free tumor DNA analysis in supernatant pleural effusions supports therapy selection and disease monitoring of lung cancer patients
10.1016/j.ctarc.2021.100449 · ExternalCitation · doi-reference
Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing
10.1016/j.ctrv.2023.102649 · ExternalCitation · doi-reference
Clinical utility of pleural effusion supernatant cell-free DNA genotyping in previously treated patients with advanced non-small-cell lung cancer and disease progression: A multicenter retrospective study
10.1016/j.esmoop.2025.106023 · ExternalCitation · doi-reference
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of clinical genome resource (ClinGen), cancer genomics consortium (CGC), and variant interpretation for cancer consortium (VICC)
10.1016/j.gim.2022.01.001 · ExternalCitation · doi-reference
Guidelines for validation of next-generation sequencing–based oncology panels: A joint consensus recommendation of the association for molecular pathology and college of american pathologists
10.1016/j.jmoldx.2017.01.011 · ExternalCitation · doi-reference
Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): An International Cancer Benchmarking Partnership (ICBP) population-based study
10.1016/s1470-2045(22)00127-9 · ExternalCitation · doi-reference
Good laboratory practice for clinical next-generation sequencing informatics pipelines
10.1038/nbt.3237 · ExternalCitation · doi-reference
Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling
10.1111/1759-7714.13006 · ExternalCitation · doi-reference
Implementation of a customized tertiary analysis platform for the reporting of somatic variants
10.1177/11772719231178618 · ExternalCitation · doi-reference
Recent advances for cancer detection and treatment by microfluidic technology, review and update
10.1186/s12575-022-00166-y · ExternalCitation · doi-reference
Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers
10.1186/s12885-022-09922-5 · ExternalCitation · doi-reference
RNA sequencing: New technologies and applications in cancer research
10.1186/s13045-020-01005-x · ExternalCitation · doi-reference
Next generation sequencing (NGS) of malignant effusions and comparison to blood liquid biopsy (ctDNA): A community experience
10.1200/jco.2025.43.16_suppl.e20661 · ExternalCitation · doi-reference
Somatic genomic testing in patients with metastatic or advanced cancer: ASCO provisional clinical opinion
10.1200/jco.21.02767 · ExternalCitation · doi-reference
ctDNA from body fluids is an adequate source for EGFR biomarker testing in advanced lung adenocarcinoma
10.1515/cclm-2020-1465 · ExternalCitation · doi-reference
Application of next-generation sequencing to realize principles of precision therapy in management of cancer patients
10.15407/exp-oncology.2024.04.295 · ExternalCitation · doi-reference
Malignant pleural effusion and cancer of unknown primary site: A review of literature
10.21037/atm.2019.06.33 · ExternalCitation · doi-reference
Clinical practice guidelines for pre-analytical procedures of plasma epidermal growth factor receptor variant testing
10.3343/alm.2022.42.2.141 · ExternalCitation · doi-reference
Exosomes in early lung cancer diagnostics: The current state of progress made and prospects
10.3389/fcell.2025.1739242 · ExternalCitation · doi-reference
Spatial transcriptomics technology in cancer research
10.3389/fonc.2022.1019111 · ExternalCitation · doi-reference
Areas of crush nuclear streaming should be included as tumor content in the era of molecular diagnostics
10.3390/cancers15061910 · ExternalCitation · doi-reference
Extracellular vesicles in lung cancer: Implementation in diagnosis and therapeutic perspectives
10.3390/cancers16111967 · ExternalCitation · doi-reference
From sample to sequencing: The importance of pre-analytical sample treatment in NGS analysis of patients with chronic lymphocytic leukemia
10.3390/cancers17223668 · ExternalCitation · doi-reference
Analysis of pre-analytic factors affecting the success of clinical next-generation sequencing of solid organ malignancies
10.3390/cancers7030859 · ExternalCitation · doi-reference
Next-generation sequencing in oncology: Genetic diagnosis, risk prediction and cancer classification
10.3390/ijms18020308 · ExternalCitation · doi-reference
Molecular profiling of malignant pleural effusions with next generation sequencing (NGS): Evidence that supports its role in cancer management
10.3390/jpm10040206 · ExternalCitation · doi-reference
